GPA stands for Granulomatosis with PolyAngiitis. It is an ANCA Associated form of vasculitis (AAV) which is a subgroup of small vessel vasculitis . Until 2012 the disease was referred to as Wegener’s disease, Wegener’s Granulomatosis or Morbus Wegener. Dr. Wegener was the pathologist who first recognized the characteristics of this syndrome as a separate disease and published an important paper about it. GPA is most common form of AAV.
Melbourne Februari 21-25 2026
The 22nd edition of this international workshop on vasculitis will take place from February 21 to 25, 2026, in Melbourne, Australia. Organized by the Australian and New Zealand Vasculitis Society (ANZVASC).
Prague 14-15 Nov 2025.
Once a year, patient representatives from across Europe gather for the European Vasculitis Patient Summit.This special meeting offers a unique platform to exchange experiences, share knowledge, and discuss current vasculitis topics.
French EGPA patients and their doctors received disappointing news recently when the French health authority (HAS) decided not to reimburse Fasenra (benralizumab) for treating EGPA. This decision has created significant concern within the EGPA community, as it limits access to what could be an important alternative treatment option.
